Clinical Control of CSU with Antihistamines Allows for Tolerance of NSAID-Exacerbated Cutaneous Disease

Author:

Sánchez Jorge,Diez Susana,Cardona Ricardo

Funder

University of Antioquia and the “IPS Universitaria” Clinic

Universidad de Antioquia

Inmunotek

Sanofi

COLCIENCIAS

IPS Universitaria

Unidad Alergológica

Publisher

Elsevier BV

Subject

Immunology and Allergy

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial;The Journal of Allergy and Clinical Immunology: In Practice;2023-07

2. Recent Updates in Understanding NSAID Hypersensitivity;Current Allergy and Asthma Reports;2023-02-09

3. Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice;The Journal of Allergy and Clinical Immunology: In Practice;2023-02

4. Drug allergy: A 2022 practice parameter update;Journal of Allergy and Clinical Immunology;2022-12

5. Aspirin/NSAID Challenge Should Be Performed Routinely in Patients With Self-Reported Aspirin/NSAID Allergy;The Journal of Allergy and Clinical Immunology: In Practice;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3